Evaluation of prognostic potential of β-catenin and L1CAM expression according to endometrial cancer risk group

CONCLUSION: The expression of nuclear β-catenin may serve as a potential biomarker for predicting recurrence and guiding therapeutic strategies in high-intermediate risk EC patients.PMID:38309030 | DOI:10.1016/j.ygyno.2024.01.044

Source: Gynecologic Oncology - February 3, 2024 Category: Cancer & Oncology Authors: Heesoo Yoon Dong Hoon Suh Kidong Kim Jae Hong No Yong Beom Kim Hyojin Kim Source Type: research